PMC:7161517 / 14166-14400
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T80 | 84-98 | Body_part | denotes | thoracic aorta | http://purl.org/sig/ont/fma/fma3786 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T42 | 14-20 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/UBERON_0000055 |
| T43 | 84-98 | Body_part | denotes | thoracic aorta | http://purl.obolibrary.org/obo/UBERON_0001515 |
| T44 | 93-98 | Body_part | denotes | aorta | http://purl.obolibrary.org/obo/UBERON_0000947 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T135 | 14-20 | http://purl.obolibrary.org/obo/UBERON_0000055 | denotes | vessel |
| T136 | 84-98 | http://purl.obolibrary.org/obo/UBERON_0001515 | denotes | thoracic aorta |
| T137 | 84-98 | http://www.ebi.ac.uk/efo/EFO_0002525 | denotes | thoracic aorta |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T191 | 49-59 | Chemical | denotes | olmesartan | http://purl.obolibrary.org/obo/CHEBI_48416 |
| T192 | 205-213 | Chemical | denotes | atenolol | http://purl.obolibrary.org/obo/CHEBI_2904|http://purl.obolibrary.org/obo/CHEBI_55352 |
| T194 | 217-228 | Chemical | denotes | hydralazine | http://purl.obolibrary.org/obo/CHEBI_5775 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T95 | 0-234 | Sentence | denotes | Comparison of vessel wall dimensions showed that olmesartan selectively reduced the thoracic aorta media-to-lumen ratio, whereas vascular hypertrophy was unchanged in spontaneously hypertensive rats given atenolol or hydralazine (44). |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T537 | 14-20 | UBERON:0000055 | denotes | vessel |
| T538 | 21-25 | UBERON:0000060 | denotes | wall |
| T539 | 84-98 | UBERON:0001515 | denotes | thoracic aorta |
| T540 | 99-104 | UBERON:0004363 | denotes | media |
| T541 | 194-198 | NCBITaxon:10114 | denotes | rats |
| T542 | 205-213 | CHEBI:2904;CHEBI:2904 | denotes | atenolol |
| T543 | 217-228 | CHEBI:5775;CHEBI:5775 | denotes | hydralazine |
| T62928 | 20-23 | PR:000001191 | denotes | wa |
| T35232 | 34-38 | PR:000003622;G_3;PG_10 | denotes | ns s |
| T26354 | 49-60 | UBERON:0001986 | denotes | olmesartan |
| T89670 | 61-72 | CHEBI:16480;CHEBI:16480 | denotes | electively |
| T84189 | 82-92 | GO:0010467 | denotes | e thoracic |
| T10845 | 115-119 | PR:000001307 | denotes | atio |
| T1909 | 120-130 | GO:0010467 | denotes | whereas v |
| T89580 | 164-168 | NCBITaxon:10114 | denotes | in s |
| T30307 | 182-193 | CHEBI:9434;CHEBI:9434 | denotes | ypertensive |
| T38415 | 228-232 | G_3;PG_10;PR:000003622 | denotes | (44 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 622 | 194-198 | Species | denotes | rats | Tax:10116 |
| 627 | 49-59 | Chemical | denotes | olmesartan | MESH:C437965 |
| 628 | 205-213 | Chemical | denotes | atenolol | MESH:D001262 |
| 629 | 217-228 | Chemical | denotes | hydralazine | MESH:D006830 |
| 634 | 129-149 | Disease | denotes | vascular hypertrophy | MESH:D006984 |
| 635 | 181-193 | Disease | denotes | hypertensive | MESH:D006973 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32305401-15833808-55252953 | 230-232 | 15833808 | denotes | 44 |